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ABSTRACT 
Hospital wastewater (HWW) can contain hazardous substances, such as pharmaceutical residues, 
chemical hazardous substances, pathogens and radioisotopes. Due to these substances, hospital 
wastewater can represent a chemical, biological and physical risk for public and environmental health. 
In particular, several studies demonstrate that the main effects of these substances can’t be neutralised 
by wastewater treatment plants (WWTPs). These substances can be found in a wide range of 
concentrations due to the size of a hospital, the bed density, number of inpatients and outpatients, the 
number and the type of wards, the number and types of services, the country and the season. Some 
hazardous substances produced in hospital facilities have a regulatory status and are treated like waste 
and are disposed of accordingly (i.e., dental amalgam and medications). Legislation is quite 
homogeneous for these substances in all industrial countries. Problems that have emerged in the last 
decade concern substances and microorganisms that don’t have a regulatory status, such as antibiotic 
residues, drugs and specific pathogens. At a global level, guidelines exist for treatment methods for 
these effluents, but legislation in all major industrial countries don’t contain limitations on these 
parameters. Therefore, a monitoring system is necessary for these effluents as well as for substances 
and pathogens, as these elements can represent a risk to the environment and public health.      
 
Keywords: Hospital wastewater, legislation, guidelines, water pollution, emerging pollutant 
  
 3 
1. Introduction 
 
In recent years, many researchers have realised that hospital wastewater (HWW) could be 
hazardous to both humans and the environment due to the presence of pathogens, pharmaceuticals 
substances, and products of laboratories and research activities. Many of these substances are 
contained in the faeces and urine of patients and are excreted as non-metabolised drugs in the sewer 
system (Orias and Perrodin, 2013; Verlicchi et al., 2010a, 2012).  
Several studies on HWW confined themselves to the investigation of a limited number of 
pharmaceutical compounds (in particular, antibiotics and anti-inflammatory drugs), their fate in the 
water management cycle and in the environment (Al Aukidy et al., 2014; Brechet et al., 2014; Boillot 
et al., 2008; Hartemann et al., 2005; Schuster et al., 2008; Verlicchi et al., 2010a).  
Only a few countries have reference standards and specific treatment methods to manage these 
effluents. For industrial effluents, however, there are specific reference standards and treatment 
methods imposed at regional or municipal levels by competent authorities, with regard to direct 
discharge (in surface waters), the reuse after suitable treatment, and discharge in a municipal 
wastewater treatment plant (WWTP) (indirect discharge).  
Some countries, in fact, consider hospital wastewater to be domestic and therefore discharged, 
directly in the municipal sewer network without any pretreatment or imposed quality limits. Reference 
standards and quality control are usually imposed only after the treatment of the WWTP effluents. In 
only few countries, hospital effluents are considered to be industrial and are pretreated before 
discharge in the municipal sewer network.  
Parameters typically set by legislation for assessing the quality of a generic wastewater sample are 
the basic physico-chemical indicators: pH, temperature (usually <40 °C), Chemical Oxygen Demand 
(COD), Biochemical Oxygen Demand (most commonly expressed in milligrams of oxygen consumed 
per litre of sample during 5 days of incubation at 20 °C (BOD5)) and Total Suspended Solid (TSS). If 
the wastewater sample is considered to be industrial or a specific effluent (such as from hospitals, in 
some cases), measurements of other specific macropollutants are required, such as Adsorbable 
Organic Halogens (AOX), total and free chlorine, detergents, disinfectants, tensioactives, oil and 
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grease, sulphates, cyanides, organophosphorates, total nitrogen, heavy metals and rarely 
microbiological indicators (total coliform, faecal coliform or Escherichia coli) and toxicity.  
An emergent concern about hospital effluents are the chemicals without regulatory status whose 
impact on the environment and human health are poorly understood. These are referred to as 
“emerging pollutants”, such as pharmaceutical compounds (antibiotics, APIs), chemical residues, 
radioelements, antibiotic resistance strains, and pathogens that don’t have a regulatory status but can 
represent a risk. In fact, the fate of these compounds in the environment and the possibility of 
reduction by the WWTPs are unknown. The introduction of these hazardous substances (particularly 
disinfectants, non-metabolised pharmaceuticals and radionuclides) into the aquatic ecosystem could 
have a heavy impact on aquatic organisms as well as for the human population, as the final recipient of 
this type of pollution (Emmanuel et al., 2005; Le Corre et al., 2012; Suarez et al., 2009; Varela et al., 
2014).  
The aims of this overview are the following: I) to describe the qualitative characteristics of hospital 
effluent, II) to analyse their possible impact on the basis of their quantity, and III) to provide 
information about the major international legislation and guidelines of this effluent.  
 
2. Characteristics of hospital wastewaters  
 
There is a wide variability of the characteristics of the hospital effluents in relationship to the size 
of hospitals, the bed density, the number of inpatients and outpatients, the number and the type of 
wards, the number and types of services, the country and the seasonality (Al Aukidy et al., 2014; 
Verlicchi et al., 2012). 
These effluents are generated from all activities of the hospital, including medical (operations, 
emergency and first aid, laboratories, diagnosis, radiology etc.) and non-medical activities (toilets, 
kitchens and laundry activities etc.), and these can be classified into two main categories:  
• domestic discharges from kitchens, laundries and toilets of normal wards; 
• specific discharges generated by care, analysis and research activities. These 
discharges can contain disinfectants, detergents, contagious faeces/excreta, biological 
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liquids, drug residues, metal radioelements, and many other chemicals (acids, alkalis, 
solvents, benzene, hydrocarbons, colorants, etc.). These effluents can potentially 
contain some hazardous substances with a genotoxic or cytotoxic activity, toxic or 
hazardous chemicals or pharmaceutical residues, and radioactive and/or infectious 
agents (WHO, 2013). 
Table 1 and Table 2 represent HWW data of physico-chemical indicators that concern facilities of 
different sizes, flow rate and countries, compared with those of urban wastewaters (UWW) plants with 
different population equivalents. These data confirm the evidence of the wide variability of 
characteristics of these effluents due to the many variables that come into play. The COD indicator 
that measures the total oxygen-depletion due to the presence of water contaminant (biodegradable and 
non-biodegradable oxidisable pollutants) shows high values for the hospital effluents.  
Concerning the macropollutants it has been shown that only ammonium ions are more concentrated 
in HWW than in the UWW, despite data being limited. 
Data of microbiological indicators indicate that total E.coli load is generally higher in urban than in 
hospital wastewater, due to the higher dilution of wastewater in hospital, in which water consumption 
per bed is high (∼700 L per day) (Brechet et al., 2014). The content of faecal and total coliform are 
greater in UWW than in HWW.  
 
2.1. Chemical riskss 
 
The main chemical substances that can be found in HWWs are antibiotics, analgesics and anti-
inflammatories, psychiatric drugs, β-blockers, anaesthetics, disinfectants, chemicals from laboratory 
activities, developer and fixer solutions from photographic film processing and X-ray contrast media 
(WHO, 2013).  
These substances are excreted mainly in the urine (55-80%), less so in faeces (4-30%), as 
unmetabolised substances, metabolites, or conjugated with inactivating substances (Alcock et al., 
1999; Al Aukidy et al., 2014; Jjemba, 2006; Verlicchi et al., 2012). These substances may have 
different behaviours in the WWTP due to their different solubility, volatility, molecular weight, 
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adsorbility and biodegradability, polarity, stability, half-life and persistency, and if they are not 
neutralised in the wastewater treatment, they are released in surface waters with treated effluents 
(Verlicchi et al., 2010a).  
Most researchers concentrated their studies on pharmaceuticals, due to the worldwide increase of 
consumption (especially antibiotics), as well as their detection in wastewaters and surface waters, and 
for their potential impact on the environment and human health, such as endocrine disruption and 
sexual disturbance in aquatic organisms (Al Aukidy et al., 2014; Diwan et al., 2013; Fick et al., 2009; 
Jean et al., 2012; Kovalova et al., 2013; Le Corre et al., 2012; Orias et al., 2013; Passerat et al., 2010; 
Santos et al., 2013; Verlicchi et al., 2010a).  
Some of these substance, (diclofenac, 17β-estradiol, 17α-ethinylestradiol), have been included in 
the European priority list (European Community Directive 2013/39, about water policy) and in the US 
contaminant candidate list (erythromycin, 17α-ethinylestradiol, 17α-estradiol, 17β-estradiol, equilenin, 
equilin, estriol, estrone, mestranol and norethindrone) that concern new substances for priority action 
(EPA, 2009). 
Studies that focus on comparisons between hospital and urban effluents have shown that the 
concentration of pharmaceuticals in hospital effluents is greater than in UWWs for almost all 
compounds, in particular antibiotics (Al Aukidy et al., 2014; Santos et al., 2013; Stalder et al., 2013; 
Verlicchi et al., 2012) (Table 3). Environmental drug contamination, however, can be derived from 
other sources, such as livestock, slaughterhouses, aquacultures, and agriculture, and in some case with 
a greater total concentration of pharmaceutical compounds (Harris et al., 2013; Lupo et al., 2012; Sim 
et al., 2013; Rizzo et al., 2013). The report on surveillance of antimicrobial consumption in Europe of 
European Centre for Disease Prevention and Control (ECDC) revealed that in Latvia and Finland, 
20% of total consumption of systemic antibacterials is derived from the hospital sector. In other 
countries, this proportion does not reach 10%, and greater consumption is derived from the community 
(domestic and commercial facilities). 
Many studies utilised the Risk Quotient (RQ) for evaluating the ecotoxicological potential of 
HWW in the environment. The risk quotient is a common method utilised for any other chemical 
hazard substances. This value is derived from the ratio of the Predicted Effect Concentration (or 
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2.2. Physical risks 
The main physical hazard derived from HWW is associated with the radioactive substances in the 
effluents, which are utilised in nuclear medicine therapies. The main isotope utilised is the 131I 
radioisotope, while other radionuclides used are typically simple beta emitters (e.g., phosphorus-32, 
strontium-89, and yttrium-90) that pose much less risk. The contamination by this radioisotope, 
derived from the excreta of treated patients, can reach levels of up to 90% of the radioactive dose 
administered, depending on the type of therapy the patient underwent. Given its radioactive half-life of 
8 days, there is a significant risk of 131I radioisotope accumulation after its discharge into the sewer 
network (through sanitary wastewater) and into the environment (Rodríguez, 2012; Tavakoli, 2005). 
The method normally utilised for abating radioactivity is the natural decomposition of the isotope, 
decay and delay, in holding tanks (8 days for 131I), before the discharge in the foul sewer. 
 
2.3. Biological risks 
 
The biological risk of HWWs is derived from the plausible presence of infectious agents. In 
general, wastewater can contain a large variety of pathogen microorganisms (bacteria, protozoa, 
helminths and viruses) that are principally derived from the faeces of infected humans and primarily 
transmitted by the faecal-oral route (enteric microorganism) and secondly by bodily fluid discharge, 
usually in small quantities.  
In Table 4 are EPA data (EPA, 2012) of the concentration of infectious agents potentially present 
in raw domestic wastewater compared with the pathogen concentration from the reviewed literature, in 
both UWWs and HWWs. The bibliography about detection of pathogenic bacteria and protozoa in the 
HWW is practically non-existent, probably because a legislation is not present and because the interest 
is focalised on other important problems, such as bacterial resistance and the detection of pathogens in 
effluents of WWTPs or in surface water. On the contrary, the enteropathogenic virus (Norovirus, 
Adenovirus, Rotavirus and Hepatitis A Virus) concentrations in hospital effluents are 2-3-fold greater 
than in UWWs (Table 4).  
  
 9 
A problem over the last decade concerns bacterial resistance to antibiotics. Bacterial resistance to 
antibiotics has become an issue of growing concern worldwide  frequently attributed to the excessive 
use of antibiotics, in particular .  
wastewater treatment plants can serve as potential reservoirs of antibiotic resistant-bacteria (ARB). 
The fate of ARB in wastewater is primarily linked to release of ARB from patients (e.g. E. coli) or 
from both patients and hospital equipment (e.g. P. aeruginosa) (Tumeo et al., 2008). Antimicrobials 
also rejected in wastewater exert a continuous selective pressure on ARB. In acute-care hospitals, the 
antimicrobial selective pressure is particularly high, for instance, 20 to 30% of European inpatients 
receive an antibiotic treatment (ECDC, 2013). In the community, only 1-3% of individuals received an 
antibiotic treatment. The selective pressure is consequently much more important in HWW than in 
UWW. Antimicrobial residues may also induce bacteria to transfer horizontally antibiotic resistance 
genes for other community members (Varela et al., 2014). Antimicrobial residues would be implicated 
in the rearrangement of the bacterial communities in surface and wastewater, supported by the 
demonstration of the significant correlation among the concentrations of antimicrobial residues, 
antibiotic resistant bacteria or their genes and rearrangements of the communities (Brechet et al., 2014; 
Gros et al., 2013; Stalder et al., 2013; Huerta et al., 2013; Novo et al., 2013; Varela et al., 2014). 
Regarding antibiotic classes, β-lactams are the most widely used group of antibiotics in inpatients, 
followed by fluoroquinolones. However, β -lactams are rarely detected in wastewater because the β -
lactam ring is readily cleaved by hydrolysis (Brechet et al., 2014). By contrast, high concentrations of 
fluoroquinolones are found in HWW,  WWTPs and downstream from the WWTP, in rivers 
(Rodriguez-Mozaz et al., 2015). This is also the case for macrolides or sulphonamides.The ARB 
represent a risk to humans and animals because they can reduce the therapeutic potential against 
pathogens.  
 
 
 
3. Production of hospital wastewater 
Regarding water consumption and the consequential production of wastewaters, the peak coefficients 
for hospital flow rates are fairly analogous to those generally assumed for the influent to a small 
WWTP (<10,000 inhabitants or population equivalent, p.e.) (Verlicchi et al., 2010a). The total 
production, however, depends on the same factors mentioned above for several characteristics 
(number of inpatients and outpatients, number of beds, number and type of wards and units, facility 
size, number and types of services), as well as on the facility age and maintenance requirements, 
cultural and geographical factors, hour of the day and the season. Other contributors include steam 
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sterilisers, autoclaves, medical processes, heating ventilation and air conditioning, sanitary, x-ray 
equipment and other services that the hospital provides (e.g., kitchen, laundry) (Diwan et al., 2013; 
Galletti et al., 2011; Wissenschaftszentrum Umwelt, 2000).  
Concerning the total effluent contribution of hospital facilities in a city, the volume unloaded in the 
municipal WWTP depend also on other factors, such as number of hospitals, industrialisation level, 
population density and the number of beds used per day. For the calculation of this percentage in 
Europe, considering that there are approximately 2.6 hospitals for every 100,000 inhabitants (ranging 
from 1 in the Netherlands to almost 6 in Finland) (EHHF, 2011), with on average 530 hospital beds 
(ranging from approximately 320 in Spain and little more than 800 in Germany) and that HWW 
discharge is approximately 0.3 to 0.7 m3 per bed a day (Boillot et al., 2008; Esher et al., 2011; 
Kovalova et al., 2013; Lienert et al., 2011; Suarez et al., 2009), the total effluents produced from these 
facilities are approximately 265 m3/d (from an average of 0.5 m3/d for hospital bed) in a city with 
100.000 inhabitants.  
In a city like Turin with 1,500,000 inhabitants with a total wastewater production of about 7.2 x 105 
m3/d (SMAT, Turin Metropolitan Water Society informative guide), the percentage of hospital 
effluents is approximately 0.6% of the total discharge treated in a municipal WWTP. In other studies, 
the percentage may be 0.2% (in a city with a 50 bed per 100,000 inhabitants hospital and a WWTP 
capacity of 55,300 m3 per day) (Le Corre et al., 2012) to 2% (Galletti et al., 2011; Korzeniewska, 
2012).   
4. Guidelines for the management of hospital wastewater 
 
The only existing guidelines concerning hospital effluents were published by the World Health 
Organization (WHO) in 1999: “Safe Management of Wastes from Health-care Activities” (WHO, 
1999) and updating in 2013 (WHO, 2013). This publication describes the methods for the treatment 
and disposal of health-care wastes, in which there is a section that concerns the collection and the 
disposal of wastewater from health-care activities.  
The WHO states that, “A large part of the wastewater from health-care facilities is of a similar 
quality to domestic wastewater and poses the same risks. Just as domestic wastewater is considered to 
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be potentially infectious, wastewater from health-care facilities must also be considered in a similar 
manner and precautions taken” but “A proportion of the generated wastewater from health-care 
facilities will pose a higher risk than domestic wastewater. Depending on the service level and tasks of 
the health-care facility, the wastewater might contain chemicals, pharmaceuticals and contagious 
biological agents, and might even contain radioisotopes” (WHO, 2013). 
In the first part, the guideline describes the hazardous characteristics of these wastewaters that 
agree with majority of studies reviewed. The second part suggests the methods of treatment of 
particular hazardous effluents. These methods are summarised in Table 5. In general, pretreatment is 
recommended for wastewater streams from departments such as medical laboratories (could include 
acid–base neutralisation, filtering to remove sediments, or autoclaving samples from highly infectious 
patients) and from the dental department, by installing an amalgam separator in sinks. Moreover, the 
minimum requirements for the discharge of HWW into a municipal sewerage system are the 
following: 
• an efficient sewage-treatment plant with primary, secondary and tertiary treatment of a municipal 
sewers that is connected to the hospital sewer; 
• the municipal sewers should be connected to a central treatment plant that ensures at least 95% 
removal of bacteria;  
• the sludge resulting from sewage treatment is subjected to anaerobic digestion, leaving no more 
than one helminth egg per litre in the digested sludge; 
• the waste management system of the health-care establishment maintains high standards, ensuring 
only low quantities of toxic chemicals, pharmaceuticals, radionuclides, cytotoxic drugs, and 
antibiotics in the discharged sewage.  
For countries operating only with basic sewage systems or those experiencing epidemics of enteric 
disease or with endemic intestinal helminthiasis, the onsite treatment, or at least pretreatment, of the 
wastewater before discharge into the municipal sewerage system should be considered. If the 
treatment plant doesn’t meet the requirements above or the hospital is not connected with a public 
wastewater treatment, the facility should have an efficient on-site wastewater treatment that includes 
primary treatment, secondary biological purification, and tertiary treatment (such as lagooning).  
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The disinfection of wastewater is often required, particularly if the wastewater is discharged into 
any body of water used for recreational activities or as a source of drinking water (including aquifers). 
Disinfection of the wastewater is particularly important if it is discharged into coastal waters close to 
shellfish habitats, especially if the dietary habits of local people include eating raw shellfish. Chlorine 
disinfection can be utilised only with the requirements described in Table 5. 
Other factors necessary include a monitoring of wastewater losses between entry points (sinks, 
toilets, drains) and an onsite treatment plant or tank or discharge point into a municipal sewage 
system. The monitoring of the wastewater system should include two aspects: monitoring the sewage 
system and monitoring effluent quality. This includes the most common parameters for monitoring the 
effluent quality (temperature, pH, BOD5, COD, nitrate, total phosphorus, total suspended solids, 
presence and concentration of Escherichia coli). Furthermore, if an onsite treatment plant is operated, 
the inflow of wastewater and the outflowing treated effluent should be tested regularly to monitor how 
efficiently the treatment plant reduces the concentration of contaminants. 
The International Commission on Radiological Protection (ICRP) has published a guideline for the 
release of patients after therapy with unsealed radionuclides. These patients who undergo radioactive 
therapy release radioactive isotopes with their excreta, Technetium-99m in particular, but its short 
half-life limits its importance, and the main concern is iodine-131, which can be detected in the 
environment but has no measurable environmental impact. The guidelines state that storing patients' 
urine after therapy appears to have minimal benefit and that the radionuclides released into modern 
sewage systems are likely to result in doses to sewer workers and the public that are well below public 
dose limits (ICRP, 2004). 
In the USA, the Environmental Protection Agency (EPA) enacted the Clean Water Act (CWA) in 
1972, which establishes effluent guidelines for facilities that discharge directly into its waters, as well 
as facilities that discharge into municipal WWTPs. In this guideline, HWW characteristics were 
described that should exist for discharge in surface waters, after the application of the Best Practicable 
control Technology (BPT) currently available (EPA, 2010). The BPT does not require the use of any 
specific technology, but the facility chooses its own approach to comply with its permit limitations. 
Concerning discharge in the municipal WWTPs, hospital facilities are considered to be a commercial 
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facility. For these categories, the authority of the WWTP may develop local limits, after the collection 
of site-specific data on pollutant loadings of facilities and on the WWTP’s capacity of removal of 
those pollutants. The concentration of pollutant loading may not exceed the maximum allowable 
headworks loading of the WWTP. If the concentration exceeds this, little or no pollutant loading is 
available for the facilities. The maximum allowable headworks loading is the estimated maximum 
loading of a pollutant that can be received at a WWTP’s headworks that should not cause a WWTP to 
violate a particular treatment plant limit or environmental criterion (EPA, 2004).  
The EPA permits that member states and local city pretreatment programs implement guidelines 
through the publication of regulations and local limits that reflect the specific needs and capabilities at 
individual WWTPs, designed for its protection, its receiving waters, and its sludge disposal practices 
(table 6).  
 
5. Normative about the hospital wastewaters 
 
In Europe there is not a specific directive or guideline for the management of hospital effluents. 
However, the European Directive n. 91 of 21 May 1991 (91/271/CEE modified from Directive 27 of 
February 1998 n. 98/15/CE) on the treatment of UWW required a pre-authorisation if the wastewater 
is considered to be industrial before discharge into UWW collection systems (as in certain country is 
considered the hospital effluent). Moreover, the European Directive n. 98 of 19 November 2008 
(2008/98/CEE) about the management of hazardous waste and the list of hazardous waste of the 
European Decision n. 532 of 3 May 2000 (2000/532/CEE) stated that some hospital liquid waste 
(pharmaceutical products, medicines, residues from substance for employed as solvents, soaps, no-
halogenated organic substance etc.) must not be discharged into a foul sewer but treated as a waste and 
collected and disposed as such. For the effluents from the hospital foul sewer, there isn’t a specific 
disposition, so member states of the European Union have their own legislation, evaluation and 
selection criteria for HWW quality and its management. 
If a hospital facility is considered, by the legislation of the state, to be industrial or like a facility 
that discharges not only domestic wastewater (as in Spain and France), specific characteristics of the 
wastewater will be required for the permission to discharge it in the municipal WWTP (Table 7); 
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usually a pretreatment is required. Instead, in a country where the HWW is considered to be domestic 
or communal, neither authorisation nor specific characteristics are required (as in Germany). 
In other cases, if the HWW complies with the specific characteristics established by the WWTP 
authority, the wastewater may be considered to be domestic effluent and discharged in WWTPs 
without any pretreatment. Even if the indicator parameters exceeded the limits imposed, the 
wastewater may be pretreated (as in Italy).  
Table 7 reports the ranges of indicator parameters for hospital effluents only for the member states 
that have a specific indication. As seen in the table, the indicators required are physic-chemical 
indicator, macropollutants (NH4, NOx, oil and grease, tensioactives, phosphorous, chlorines and 
others) and in some rare cases, microbiological indicators (typically E.coli).  
Table 5 reports how special liquid wastes derived from special hospital activities (care, diagnostic 
tests, analysis and research activities) are treated in different member states. According to the source 
and the type of substance, the method of treatment changes. When the effluent isn’t considered 
hazardous, it can be discharged in the foul sewer, as is the case for small quantities of blood or other 
bodily fluids. However, discharge in foul sewers is prohibited for all pharmaceutical residues. For 
other specific chemical substances, if the chemical is included on the list of hazardous substance of the 
European Decision n. 532, it will be treated as hazardous waste.  
For radioactive excreta derived from patients treated with radioactive therapy, despite what is 
stated in the ICRP, every member state must adopt their own method of treatment, as shown in Table 
5. Some countries permit discharge in the urban sewage system without a septic tank collection system 
(Spain, Great Britain, Republic of Ireland), but in the majority of cases only if it has been 
demonstrated that the radioactivity does not exceed the limits imposed by a competent authority of 
sanitary sewers (Rodrígez, 2012). For France, Germany, Northern Ireland, Lithuania, Luxemburg, and 
the Netherlands, effluents eliminated by patients should be collected in protected rooms and linked to 
a septic tank for delay and decay. Some of these countries require compliance with some reference 
limits before discharge into the sewer (Germany and Luxemburg 5 Bq/l and Northern Ireland 80 
KBq/l), while other countries impose a time limit on storage (from 30 to 60 days for Lithuania, 210 
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days for Luxemburg or for up to 2 years for radionuclides with half-lives below 100 days for the 
Netherlands). In Italy, the Legislative Decree n. 230 of 17 March 1995 (Dlgs, 1995) on radioactive 
waste does not precisely indicate a method, but the excreta are usually stocked in specific septic tanks 
for approximately 10 hours for the decay of 131I (Bagnato et al., 2003).  
As seen in most other countries, hospital discharges require a specific consent issued by competent 
authorities (WWTPs) because they are considered to be industrial (China, India) or a facility that 
discharges only domestic sewage that required a specific licence. In Brazil, HWW is in a category of 
domestic and municipal wastewater that does not require specific limitations for discharge in WWTPs, 
only for discharge in surface water.  
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6. Conclusion 
HWW is generated from all hospital activities, both medical and non-medical, and can be classified into two 
main categories: domestic wastewater (kitchens, laundries and patient of normal ward) and specific wastewater 
(generated by care, analysis and research activities). Over the past few years, different studies have provided 
information about the potential presence of hazardous substances in these discharges (disinfectants, detergents, 
contagious faeces/excretions, drug residues, metals, radioelements, acids, alkalis, solvents, benzene, 
hydrocarbons, colorants). 
From these studies emerged differences in the physico-chemical parameters and faecal indicators. The 
differences between hospital effluent and UWW were not significant. Moreover, this information doesn’t 
provide an indication on the hazard of these effluents. For hazardous chemical compounds, the most hazardous 
ones are considered to be waste and are treated as such (i.e., dental amalgam, pharmaceutically active 
medications). Antibiotics and other pharmaceutical residues that are discharged with the excreta of patients are 
the substances of greatest concern due to the high concentration of these substances in effluents. The 
concentrations can reach five-fold the UWW concentration, in particular for some of the following substances: 
Ofloxacin, 17α-ethinylestradiol, erythromycin and sulfamethoxazole (Al Aukidy et al., 2014). Their fate and 
behaviour in the environment and their interaction with other substances and/or microorganisms are in part 
unknown. In fact, several studies demonstrate that the majority of pharmaceutical and personal care products are 
not eliminated from the liquid phase during wastewater treatment, especially for substances with low 
lipophilicity (Castiglioni et al., 2005; Suarez et al., 2009). Releasing these substances in the environment can 
exceed their PNECs (Verlicchi et al., 2012) and can present a risk to the aquatic organisms and public health 
(i.e., endocrine disruptors), and they can interact with other substances, generating a synergistic effect (Sim et 
al., 2013). 
 From the point of view of biological hazards, there is an important shortcoming in assessing pathogen 
concentration in these effluents. Several studies demonstrate that commonly used bacterial indicators are 
unreliable in terms of detecting pathogen contamination, and often no correlation between levels of enteric 
bacteria, enteric viruses and other pathogens has been found (Ahmed et al., 2013; Haramoto et al., 2006; Muela 
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et al., 2011; Ottoson et al., 2006). Furthermore, WWTPs are not suitable systems for the total removal of 
pathogens present in these effluents (Prado et al., 2011).  
The lack of information on the chemical and pathogen characteristics of these wastewaters is in part due to 
the absence of specific guidelines. The major industrial countries have their own methods of treatment for these 
effluents, but none have a specific pharmaceutical residue and pathogen limitation before discharge in WWTPs 
or in surface water.  
The frequency of detection and quantification of these substances, and in particular for pathogens, could be 
variable according to pathogen type, the different health care centres effluents are derived from, geographic 
regions and the epidemiological community profile (Prado et al., 2011). For these reasons, it would be 
appropriate from the perspective of public health, water and environment protection and for a possible reuse of 
the wastewater, for every country to monitor their own pathogen circulation, concentration of pharmaceutical 
residues and bacteria resistance in the hospital effluent and in WWTPs. The risk of contamination depends on 
the dilution factor, which is the volume of hospital effluents in the total UWWs, and on dilution factor of the 
surface water (Verlicchi et al., 2012). However, from a hygienic point of view, it is important not to 
underestimate the hazard for the promotion of public health. 
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Figure 1. Representation of the levels where EPA effluent guidelines operate. 
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Table 1. Mean values of physico-chemical indicators of HWW and UWW, from the reviewed studies. 
  
References Country Beds/ 
Population 
equivalent 
Flow 
Rate 
[m3/d] 
pH TSS  
(Total Suspended 
Solid) [mg/L] 
COD 
[mg/L] 
BOD5 
[mg/L] 
NH4+ 
[mg/L] 
Total P 
[mg/L] 
Fats and 
Oils 
[mg/L] 
Total 
Detergents  
[mg/L] 
HWW Verlicchi et al. 
2010b 
Italy 300      33 4  4.9 
 
Galletti et al. 
2011 
Italy 300 180  227±57 
 
480±12
5 
 
240±82 
 
42±9 
 
6±2   
 
Nafo 2012  Germany 560 90±21.4 6.8±0.
2  
97±33 709±28
0 
325±112   8.3±1.3     
 
Suarez et al . 
2009 
Spain 750 429±63  8.1 191.7 970.7       22.5   
 
Varela et al. 
2014 
Portugal 1120 1000  305 622 278     
 
Prayitno et al. 
2013 
Indonesia 
   8.1 61.1 198.5 143.7       0.63 
  
Chagas et al. 
2011 
Brasil 
  432  7.5   379.9 100 11.1       
  
Prado et al. 
2011 
Brasil 
  325.7  7   221.3 68 9       
  
Sarafraz et al. 
2007 
Iran 
  43 7.42 231.25 628.1 242.25         
  
Liang 2007 China 
    6-9 170 320 150         
 
Periasamy et al., 
2013 
India 
  7.5 126.6 662.9 129.3     
 
Verlicchi et al. 
2012 
Italy 
  8 160 650 200 30 5 25 4.5 
  
Tahiri et al. 
2012 
Marocco 
    8   318 76.6         
UWW 
Inlet 
Galletti et al. 
2011 
Italy 5000 1200  41±15 180±74 70±43     
 
Galletti et al. 
2011 
Italy 230000 35000 7.6 85 109 72 26 3   
 
 
Varela et al. 
2014 
Portugal 200000 1100000  
 
334 699 488     
 
Muela et al. 
2011 
Spain 500000 120000 7.8 65.8 210.6 123.6 28.2    
 
Zhou et al. 2012 China 412500 200000  216.7 415.2 197.5     
 
Verlicchi et al. 
2012 
 
       4-10 50-150 4-8 
  
Mungray et al., 
2011 
 India 
  71500    238 803 243.5         
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Table 2. Microbiological characteristics of the HWW and of the UWW from the reviewed studies. 
  References Country Total coliforms 
MPN/mL 
Faecal coliforms 
MPN/mL 
E.coli 
MPN or CFU/mL 
HWW Verlicchi et al. 2012 Italy   105-107 [1] 
Korzeniewska et al., 2012 Poland 
  3 x 106- 1.6 x 107 
[2] 
Prayitno et al., 2013 Indonesia 
 1.3x103  
Chagas et al., 2011 Brasil 7.4x105 0.8x105  
Liu et al., 2010 China 
   
Periasamy et al., 2013 India 1.3x103 2.2x102  
Tahiri et al., 2012 Marocco 2 x 104 1.5 x 103  
 
Galvin et al., 2010 Ireland 
  5.4 x 106 [1] 
 
Brechet et al., 2014 France 
  3.5 x 105 [2] 
 
Kwak et al., 2015 Sweden 
  3.7 x 104 [2] 
 
Oberlè et al., 2012 France 
  8.3 x 104 [2] 
UWW 
Inlet 
Verlicchi et al., 2012 Italy 107-108 106-107 106-107 [1] 
Korzeniewska et al., 2012 Poland 
  5.5 x 107 [2] 
McLellan et al., 2010 USA 
  1.1 x 106 [2] 
Levantesi et al., 2010 Europe 
  2.4 x 105- 3.6 x 106 
[2] 
Mungray et al., 2011  India 5.4x1012 1.5x1012  
 
Brechet et al., 2014 France 
  7.5 x 105 [2] 
 
Kwak et al., 2015 Sweden 
  7.4 x 104 [2] 
 
Oberlè et al., 2012 France 
  3.9 x 106 [2] 
 
[1] MPN/mL 
[2]CFU/mL 
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Table 3. Concentrations of different types of pharmaceuticals in the HWW and in the UWW from the reviewed studies. 
  Antibiotics  
[ng/L] 
Anti-infiammatories drugs  
[ng/L] 
β-blochers  
[ng/L] 
Psychiatric 
drugs 
 [ng/L] 
References Beds HWW 
  
Ciprofloxacin Clarithromycin Erytromycin Ofloxacin Sulfamethoxazole Diclofenac Ibuprofen Salicylic 
Acid 
Ketoprofene Atenolol Carbamazepine 
Galletti et 
al. 2011 
300 11768 59 165 18605 4240 304 1674 1320 5027 5131 733 
Galletti et 
al. 2011 
900 13487 6589 127 20032 1921 395 1813 1745 1289 4409 956 
Varela et al. 
2014 
1120 880   590 890       
Santos et al. 
2013 
350 4093 59.4 575 6543 1351 58 4964 1419 369 858 445 
Passerat et 
al. 2010 
 n.d.   2200 1800       
Kovalova et 
al. 2013 
346 15700±8000 1280±840 140   858±186    23±24 235±128 
Diwan et al. 
2013 
350-570 1025   218 535       
Gros et al. 
2013 
400 6411.5 543  6673 132.5       
Chang et al. 
2010 
 121.3  137 2905 623       
Sim et al. 
2011 
 1980  330  25300 1920 nd 126000   827 
Sim et al. 
2013 
     21000 1120 813  299 43000 227 
 Population 
equivalent 
UWW Inlet 
Galletti et 
al. 2011 
230000 2212 308 58 1004 443  1026 498 168 2081 581 
Varela et al. 
2014 
200000 440   340 830       
Santos et al. 
2013 
213000 221 ± 88 22.2 ± 17.8 92.7 ± 77.9 946 ± 
1790 
912 ± 391 69.7 ± 89.4 1596 ± 
1715 
51.8 ± 92.6 458 ± 112 522 ± 132 565 ± 74 
Passerat et 
al. 2010 
 n.d.   2200 1800       
Gros et al. 
2013 
112575 529 408.5  343 285.5       
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Aukidy et 
al. 2012 
120000 154.5 192.5   94 502   22 264 182.5 
Chang et al. 
2010 
 458±78  206±47 780±132 2020±368       
Sim et al. 
2011 
 182  23  254 237 nd 176000   1920 
Sim et al. 
2013 
     108 403 1880  928 14600 50 
 
Type of 
Factory 
Factory effluent 
Chang et al. 
2010 
Swine 
nursery 
nd  nd 8±2 nd       
Chang et al. 
2010 
Slaughter 
house 
11±1  nd 24±3 212±43       
Sim et al. 
2011 
Livestock  
wastewater 
nd  139  7950 nd nd 313   167 
Sim et al. 
2013 
Livestock  
wastewater  
    4310 109 12800  nd nd 3320 
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Table 4. Infectious agents present in untreated domestic wastewater (EPA, 2012), in UWW and in HWW, from the reviewed studies. 
 
  
Pathogens 
N° in 
Domestic 
Wastewater 
[per L] 
 
UWW 
Inlet 
 
HWW 
Bacteria 
 
Shigella >104    
  Salmonella >105 103-106 
copies/100mL(7)** 
  
  Campylobacter >104    
Protozoa  
[(oo)cysts/L] 
Giardia >105 103 (2)   
  Cryptosporidium >104 5 (2) 
 
  
Elminths  
[eggs/20L] 
  >103 0-2 (4)   
Viruses 
[genomic 
copies/L] 
Enterovirus >106 10 4 (2)* 
2.7x105(6)** 
  
  Norovirus  1.6x102 (2)* 2.4x106(1)** 
  Adenovirus >106 1.6x102 (5)** 2.8x106 (1)** 
  Rotavirus >105 2x10 (5)** 1.9x106 (1)** 
  Hepatitis A 
Virus 
  10 2 (3) 
5.5x105 (6)** 
10 4 (1)** 
(1) Prado et al. 2011    
(2) Ottoson et al. 2006    
(3) Villar et al. 2007    
(4) Levantesi et al. 2010 
(5) Hellmér et al. 2014 
(6) Kamel et al. 2011 
(7) Zhang et al. 2013  
*RT-PCR method 
**qRT-PCR method 
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Table 5. How special liquid wastes are treated in different countries in Europe. 
 
 
WHO GUIDELINE Italy UK Spain  Germany France 
Disinfection of wastewater Disinfection by chlorine is 
only recommended if it 
can be ensured that the 
organic matter 
is below 10 mg/l. 
 
Not obligatory  
 -  Established from 
comunal laws but 
recommended for 
infectious diseases wards 
Automated analyser 
systems 
 Collect waste liquids in 
plastic reservoir 
containers must not be 
discharged to the drain 
but collected by 
specialist waste 
contractors for recovery 
or disposal. 
Collect waste liquids in 
plastic reservoir 
containers must not be 
discharged to the drain 
but collected by 
specialist waste 
contractors for recovery 
or disposal. 
-  Collect waste liquids in 
plastic reservoir 
containers must not be 
discharged to the drain 
but collected by 
specialist waste 
contractors for recovery 
or disposal. Liquid body 
fluids residuos must be 
discharged. 
Reagents (crystal violet, 
iodine and neutral 
red or dilute carbol fuchsia 
etc..) 
Liquid laboratory 
hazardous waste 
(colorants, formalin) 
should be collected 
separately. 
 
 Disposal of these 
reagents is via dilution 
with tap water to foul 
sewer is permitted 
-  Established from 
comunal laws  
Liquid body fluids Small quantities of blood 
can be discharged 
in the sewer without 
pretreatment. 
 
The discharge of small 
quantities of blood are 
permitted if they aren't 
contained in a container 
(Indirect discharge, 
considered like a waste).  
Faeces and urines are 
discharged in foul sewer 
without a pre-treatment 
The 
Sewerage Undertakers* 
permit the discharge of 
bodily fluids to foul 
sewer under normal 
working 
conditions 
The discharge of bodily 
fluids to foul sewer is 
permitted but is required 
a pre-treatment if the 
hospital is not connected 
to municipal treatment 
plant. 
In some municipality 
into a quantity of 100 ml 
is permitted the 
discharge in foul sewer 
Bulk blood and blood 
products may be 
decanted into a sewer 
system connection 
(sinks, drains, etc.) after 
disinfection  
Excretions of invective 
enteric patients must be 
disinfection before the 
discharge 
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Preservatives and fixatives 
(alcohols, acetones and 
others) 
Photochemicals, aldehydes 
(formaldehyde and 
glutaraldehyde), colorants 
and 
should not be discharged 
into wastewater 
 
- Alcohols, acetone, and 
fixative is may be safely 
discharged to foul sewer 
in small quantities with 
considerable dilution. 
Petroleum spirit 
(benzene, toluene, ethyl 
benzene etc..) is 
statutorily prohibited 
-  Established from 
comunal laws  
Laboratory smalls  Must not be discharged 
to foul sewer 
Must not be discharged 
to foul sewer 
-  Must not be discharged 
to foul sewer 
Pharmaceutically active 
medications 
Should not be discharged 
into wastewater 
 
Must not be discharged 
to foul sewer 
Must not be discharged 
to foul sewer 
- Must not be discharged 
to foul sewer 
May be required a 
specific authorization 
Non-pharmaceutically 
active medications (ex. 
glucose solution, saline 
solution, liquid nutritional 
feeds and supplements) 
 - May be 
discharged to sink in 
small quantities (less 
than 1 litre) 
-  Established from 
comunal laws  
Radioactive aqueous 
discharges and radio 
contrasting compounds 
Radioactive wastewater 
from radiotherapy (e.g. 
urine of patients 
undergoing thyroid 
treatment) should be 
collected separately and 
stored in a secured place 
until the levels of 
radioactivity have 
decreased to background 
concentrations. After the 
required storage time, the 
wastewater can be 
disposed of into a sewer. 
 
Radioactive effluents 
eliminated by patients 
should be collected in 
protected rooms and 
linked to a septic tank 
for the delay and the 
decay. 
May be discharged to 
foul sewer if the 
radioactivity not exceed 
limits imposed from 
Sewerage Undertakers. 
Radio Contrasting 
Compounds (barium 
sulphate) not be 
discharged  
Excretion of patients 
can be discharged 
before 48 hours from 
the cytotoxic treatment  
 Urines of patients treated 
with  radioelements with 
short half-life time must 
be collected in protected 
rooms and linked to a 
septic tank for the delay 
and the decay but 
radioelements with long 
half-time must be treated 
from specific agencies  
Autopsy theatre  - Bodily fluids, blood and 
urine, stomach contents, 
faecal matter and water 
of cleaning and 
disinfection may be 
discharged to foul sewer 
-  Must be pre-treatment 
before the discharge 
Operating theatre Small quantities of rinsing 
liquids, body fluids and 
the contents of suction 
-  -  Wastewater of clining 
may be discharged to 
foul sewer 
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systems from non-
infectious patients 
 from theatres, operating 
theatre and intensive care 
can be discharged 
in the sewer without 
pretreatment. 
While stool, vomit and 
mucus from highly 
infectious patients (e.g. 
cholera patients) should be 
collected separately 
and thermally treated 
before disposal (e.g. by an 
autoclave reserved for 
waste treatment). 
 
Dental amalgam Wastewater from the 
dental department should 
be pretreated by installing 
an amalgam separator in 
sinks, 
particularly those next to 
patient treatment chairs. 
Dental liquid wastes 
containing amalgam 
don't be discharge into 
public sewer lines 
  Dental liquid wastes 
containing amalgam 
shall be discharged into 
public 
sewer lines only if a 
discharge license has 
been issued by the 
appropriate German 
Federal State 
authority 
Wastewater from the 
dental department should 
be pretreated by 
installing an amalgam 
separator in sinks 
 
 * Sewer Undertaken: the water company appointed by the Secretary of State or as the sewerage undertaker for a particular area  
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Table 6. Guidelines about the limitations of health-care facilities wastewaters.  
 
   
Limitations 
Guideline Source Year For hospital 
effluents before the 
discharge in 
municipal WWTP 
For the effluent 
from hospital 
WWTP 
Direct unloading on 
surface water 
Effluent Guidelines and Standards 
(CFR 40)  (with updatings) 
EPA 2013 Local limits 
established from 
WWTP autority 
●pH = 6.0-9.0   
●BOD5 [kg/1000 
occupied bed] 33.6 
●TSS [kg/1000 
occupied bed] 33.8    
Not indicated  
Safe management of wastes from 
healthcare activities 
WHO 2013 No limitation ●no more than one 
helminth egg per 
litre in the digested 
sludge 
 Not indicated 
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Table 7. Limits of indicator parameters from guidelines, European Directives and the legislation of member states that have a specific indication for hospital 
effluents (or for categories that include hospital facilities). 
Law Source Year For hospital effluents before the 
discharge in municipal WWTP 
For the effluent from 
hospital WWTP  
Direct unloading on surface 
water after a pretreatment 
Directive 91/271/CEE on hazardous waste 
(modified from Dir. 27-2-1998 n. 98/15/CE) 
UE 1998 Not indicated Not 
indicated 
 Not indicated 
DPR n. 227/2011 on simplification on environmental law  
 
 
 
 
 
 
 
 
 
 
 
Italy 2011 To avoid the pretreatment 
(Domestical wastewater): 
●Flow rate [m3/d] ≤15 
●pH 5.5-9.5 
●T°C ≤30 
●Color not perceptible with diluition 
1:40 
●Material roughness absent 
●TSS [mg/L] ≤700  
●BOD5 [mg/L O2] ≤300 
●COD [mg/L O2] ≤700 
●COD/BOD ≤2.2 
●P tot [mg/L] ≤30 
●NH4 [mg/L] ≤50 
●NO2- [mg/L] ≤0.6 
●NO3- [mg/L] ≤30  
●Oil and grease [mg/L] ≤40 
●Tensioactive [mg/L] ≤20 
●E.coli UFC/100ml <5000 (advised) 
Not indicated Not indicated 
DLgs n.152/2006 on environmental protection   Italy 2006 Not indicated Not indicated ●pH 5.5-9.5 
●T°C ≤35 
●Color not perceptible with 
diluition 1:20 
●Material roughness absent 
●TSS [mg/L] ≤80  
●BOD5 [mg/L O2] ≤40 
●COD [mg/L O2] ≤160 
●COD/BOD ≤2.2 
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●P tot [mg/L] ≤10 
●NH4 [mg/L] ≤15 
●NO2- [mg/L] ≤0.6 
●NO3- [mg/L] ≤20  
●Oil and grease [mg/L] ≤20 
●Tensioactives [mg/L] ≤2 
●Total hydrocarbons [mg/L] ≤5 
●Fenols [mg/L] ≤0.5 
● Aldehydes[mg/L] ≤1 
● Organic aromatic solvents [mg/L] 
≤0.2 
● Organic nitrogen solvents [mg/L] 
≤0.1 
●Pesticides phosphorus [mg/L] 
≤0.1 
●Total Pesticides [mg/L] ≤0.05 
●Chlorinated solvents [mg/L] ≤1 
●Total cyanides [mg/L] ≤0.5 
●Sulphites [mg/L] ≤1 
●Sulphurs [mg/L] ≤1 
● Sulphates [mg/L] ≤1000 
● Fluorines [mg/L] ≤6 
● Active free clorine [mg/L] ≤0.2 
●E.coli UFC/100ml <5000 
(advised) 
●Acute toxicity test: sample not 
excepted if after 24h the organisms 
death are≥50%  
[2] 
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Decreto n.26042-S-MINAE on management of discharges 
and reuses of effluents  
Spain 1997 All categories of activities: 
●T [C°] ≤40 
●pH 6-9 
●BOD5 [mg/L] ≤300   
●COD [mg/L] ≤1000 
●SS [mg/L] ≤500  
●Oil and grease [mg/L] ≤100 
●Cyanides  [mg/L] ≤2 
●Sulfates [mg/L] ≤500 
●Fluorines [mg/L] ≤10 
●Clorines [mg/L] ≤500 
●Organophosphorates [mg/L] ≤0.1 
●Carbamates [mg/L] ≤0.1 
●Organochlorines [mg/L] ≤0.05 
[2] 
Not indicated All categories: 
●T [C°] 15-40 
●pH 5-9 
●Sedimental Solids [mg/L] ≤1  
●Floating Material [mg/L] Absent 
●Total cyanides [mg/L] ≤1 
●Sulphites [mg/L] ≤1 
●Sulphurs [mg/L] ≤25 
●Fluorines [mg/L] ≤10 
●Clorines [mg/L] ≤1 
●Organophosphorates [mg/L] ≤0.1 
●Carbamates [mg/L] ≤0.1 
●Organochlorines [mg/L] ≤0.05 
For Hospital also:  
●Fecal Coliforms [CFU/100 ml] 
≤1000  
[2] 
Decreto 57/2005 (that modifies the annexes of the Law 
10/1993 on industrial effluents) 
 
Spain 2005 Sanitary activities: 
●T [C°] ≤40 
●pH 6-10 
●BOD5 [mg/L] ≤1000 
●COD [mg/L] ≤1750 
●SS [mg/L] ≤1000 
●Oil and grease [mg/L] ≤100 
●Cyanides  [mg/L] ≤5 
●Conductivity [µS/cm2] ≤7500 
●Total cleaning [mg/L] ≤30 
●Fluorines [mg/L] ≤15 
●SO4- [mg/L] ≤1000 
●H2S [mg/L] ≤5 
●Toxicity [(1/ CE50)x100] ≤25 
●AOX [mgCl/L] ≤5 
●P tot [mgP/L] ≤40 
●N total [mgN/L] ≤125 
[2] 
Not indicated Not indicated 
Urban Waste Water Treatment Regulation England 
and Wales 
1994 Not indicated ●BOD5 [mg/L O2] 25 
●COD [mg/L O2] ≤125 
●P tot [mg/L P] ≤2 (10.000 
- 100.000 e.i.) ≤1 (>100.000 
e.i.) 
Not indicated 
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●N [mg/L N] ≤15 (10.000 - 
100.000 e.i.); ≤10 
(>100.000 e.i.) 
Waste Water Ordinance (AbwV)  Germany 2004 Not indicated Domestic and communal 
wastewater category (i.e. 
Hospitals): 
●BOD5 [mg/L] 15-40 
●COD [mg/L] 75-150 
●TSS [mg/L] ≤35 
●NH4 [mg/L] ≤10  
●N total [mg/L] 13-18 
●P total [mg/L] 1-2 
 
 
Integrated Wastewater Discharge Standard (GB8978-88) 
and m. 
 
China 
 
1998 
 
Industrial categories: 
●pH 6-9 
●SS [mg/L] 0*-400 
●BOD5 [mg/L] 0*-300 
●COD [mg/L] 0*-500 
●Fluoride [mg/L] ≤20 
●Phosphorus [mg/L] ≤0.3 
●AOX (as Cl) [mg/L] ≤8 
●Fecal coliform [indivudual/L] 1000**-
5000 
●Total Clorine after disinfection >2 or 
>5** (contact time ≥1h) 
[3] 
 
Not indicated 
 
All categories: 
●pH 6-9 
●Color [mg/L] 50-80 
●SS [mg/L] 70-200 (70-150)b 
●BOD5 [mg/L] 30-60 (20-30)b 
●COD [mg/L] 100-150 
●Ammonia nitrogen [mg/L] 15-25 
●Fluoride [mg/L] ≤10 
●Phosphate [mg/L] 0.5-1.0 
●Phosphorus [mg/L] 0.1-0.3 
●Fecal coliform [individual/L] 500-
1000 and 100**-500** 
●Total Clorine after disinfection 
<0.5- >3 (contact time ≥1h) and 
>5**- >6.5**(contact time ≥1.5h) 
[3] 
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Resolução n.430/2011 Brazil 2011 Not indicated ●pH = 5-9 
●T°C <40 
●TSS [mg/L] ≤1 
●Flow 1.5 time mean flow 
●BOD5 [mg/L] ≤120 
●Oil and grease [mg/L] 
≤100 
All categories: 
●pH = 5-9 
●T°C <40 
●TSS [ml/L] ≤1 
●Flow 1.5 time mean flow 
●BOD5 -60% of untreated sewage 
●Mineral Oil [mg/L] ≤20 
●Grease [mg/L] ≤50 
[3] 
S O 630 E 20/7/1998 The Bio Medical Waste 
Management and Handling Rules  
India 1998 Industrial category (ex. Hospitals): 
●pH = 5.5-9.0   
●BOD3 (3 days at 27°C) [mg/L] <350 
●COD [mg/L] <250 
●SS [mg/L] <600 
●Oil and grease [mg/L] ≤20 
●Ammonical Nitrogen (N) [mg/L] ≤50 
●Radioactive materials [Curie/ml] 10-
6-10-7 
●Bio-assay test 90% survival of fish 
after 96 hours in 100% effluent.   
Not indicated Hospital category: 
●pH = 6.3-9.0   
●BOD5 [mg/L] <30 
●COD [mg/L] <250 
●SS [mg/L] <100 
●Bio-assay test 90% survival of 
fish after 96 hours in 100% effluent.   
 
      
*for urban secondary sewage treatment plant 
** from the contagious hospital 
     
[1] eutrophic area 
     
[2] other heavy metals  
[3] for others parameters view the law 
 
     
 
 
 
 
 
